
Mobeus sells Biosite to Assa Abloy
Mobeus has fully exited its significant minority stake in Biosite to Swedish trade buyer Assa Abloy.
Unquote understands that the deal value is £25-50m.
The management have retained a minority stake in the company. The entire management team, except for the company's technical director, will stay on in their positions.
Mobeus investment partner Amit Hindocha said: "The offer came from an inbound approach from Assa Abloy. They were one of a small number of trade buyers we identified that would be appropriate buyers. The management team felt comfortable with their team and we were able to agree a deal without having to run a wider process."
Assa Abloy is a Stockholm-headquartered corporation. It offers products and services ranging from locks, doors, gates and entrance automation. The company had a market capitalisation of SEK 242.87bn at the time of publication. Said Hindocha: "It's a huge business with great exposure that will increase the potential for Biosite's international expansion."
Previous funding
Mobeus invested an initial £2.75m in 2016 from its VCT funds. The firm later invested another tranche of £3m. During the investment period, Biosite made two small acquisitions and expanded into France, other parts of continental Europe and the US. The company's debt facilities were provided by Bank Leumi.
Company
Founded in 2010 and headquartered in Solihull, Biosite's product range includes biometric access control, wireless fire alarms, online induction, corporate reporting, delivery management, CCTV, document management and security guards. Biosite has grown annual revenues from £4.5m to £14m and staff from 50 to 180 since 2016, according to a statement. The company is EBITDA positive.
People
Mobeus – Amit Hindocha (investment partner).
Biosite – Li Wang (managing director).
Advisers
Vendor – PwC (corporate finance); Browne Jacobson (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater